Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Untch, M., Fasching, P. A., Konecny, G. E., Hasmueller, S., Lebeau, A., Kreienberg, R., Camara, O., Mueller, V., du Bois, A., Kuehn, T., Stickeler, E., Harbeck, N., Hoess, C., Kahlert, S., Beck, T., Fett, W., Mehta, K., von Minckwitz, G. and Loibl, S. (2010). Pathological Complete Response after Neoadjuvant Chemotherapy plus Trastuzumab Treatment Predicts Survival and Detects a Patient Subgroup at High Need for Improvement of Anti-HER2 Therapy. Three Year Median Follow-Up Data of the TECHNO Trial. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

von Minckwitz, G., Kaufmann, M., Kuemmel, S., Fasching, P. A., Eiermann, W., Blohmer, J. U., Costa, S. D., Hilfrich, J., Jackisch, C., Gerber, B., Barinoff, J., Huober, J., Hanusch, C., Konecny, G., Fett, W., Stickeler, E., Harbeck, N., Mehta, K., Loibl, S. and Untch, M. (2011). Local Recurrence Risk in 6377 Patients with Early Breast Cancer Receiving Neoadjuvant Anthracycline-Taxane plus /-Trastuzumab Containing Chemotherapy. Cancer Res., 71. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

This list was generated on Fri Mar 29 16:00:35 2024 CET.